Clinical Trial Update: Cancer Vaccine Targeting Brachyury Protein in Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial update for a cancer vaccine targeting brachyury protein in tumors; study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma
• Colon Neoplasms
• Malignant Solid Tumors
• Neoplasms

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasms, Malignant Solid Tumors | Phase 1 | Status: COMPLETED | Results posted: 2017-07-31